198 related articles for article (PubMed ID: 38216431)
1. Do the therapeutic effects of psilocybin involve actions in the gut?
Reed F; Foldi CJ
Trends Pharmacol Sci; 2024 Feb; 45(2):107-117. PubMed ID: 38216431
[TBL] [Abstract][Full Text] [Related]
2. The Therapeutic Potential of Psilocybin.
Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
Molecules; 2021 May; 26(10):. PubMed ID: 34063505
[TBL] [Abstract][Full Text] [Related]
3. Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
Wulff AB; Nichols CD; Thompson SM
Neuropharmacology; 2023 Jun; 231():109504. PubMed ID: 36921889
[TBL] [Abstract][Full Text] [Related]
4. Psilocybin--summary of knowledge and new perspectives.
Tylš F; Páleníček T; Horáček J
Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
[TBL] [Abstract][Full Text] [Related]
5. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.
Hesselgrave N; Troppoli TA; Wulff AB; Cole AB; Thompson SM
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33850049
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights into psychedelic drug action.
Slocum ST; DiBerto JF; Roth BL
J Neurochem; 2022 Jul; 162(1):24-38. PubMed ID: 34797943
[TBL] [Abstract][Full Text] [Related]
7. Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.
Kiilerich KF; Lorenz J; Scharff MB; Speth N; Brandt TG; Czurylo J; Xiong M; Jessen NS; Casado-Sainz A; Shalgunov V; Kjaerby C; Satała G; Bojarski AJ; Jensen AA; Herth MM; Cumming P; Overgaard A; Palner M
Mol Psychiatry; 2023 Sep; 28(9):3829-3841. PubMed ID: 37783788
[TBL] [Abstract][Full Text] [Related]
8. Towards an understanding of psychedelic-induced neuroplasticity.
Calder AE; Hasler G
Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
[TBL] [Abstract][Full Text] [Related]
9. Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.
Meccia J; Lopez J; Bagot RC
Psychopharmacology (Berl); 2023 Jan; 240(1):27-40. PubMed ID: 36564671
[TBL] [Abstract][Full Text] [Related]
10. Psychedelia: The interplay of music and psychedelics.
Jerotic K; Vuust P; Kringelbach ML
Ann N Y Acad Sci; 2024 Jan; 1531(1):12-28. PubMed ID: 37983198
[TBL] [Abstract][Full Text] [Related]
11. Psychedelic drugs for psychiatric disorders.
da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
[TBL] [Abstract][Full Text] [Related]
12. The promises and perils of psychedelic pharmacology for psychiatry.
McClure-Begley TD; Roth BL
Nat Rev Drug Discov; 2022 Jun; 21(6):463-473. PubMed ID: 35301459
[TBL] [Abstract][Full Text] [Related]
13. The varieties of psychedelic law.
Marks M
Neuropharmacology; 2023 Mar; 226():109399. PubMed ID: 36565855
[TBL] [Abstract][Full Text] [Related]
14. Potential Therapeutic Effects of Psilocybin.
Johnson MW; Griffiths RR
Neurotherapeutics; 2017 Jul; 14(3):734-740. PubMed ID: 28585222
[TBL] [Abstract][Full Text] [Related]
15. Psychedelic Psychiatry's Brave New World.
Nutt D; Erritzoe D; Carhart-Harris R
Cell; 2020 Apr; 181(1):24-28. PubMed ID: 32243793
[TBL] [Abstract][Full Text] [Related]
16. Psilocybin occasioned mystical-type experiences.
James E; Robertshaw TL; Hoskins M; Sessa B
Hum Psychopharmacol; 2020 Sep; 35(5):e2742. PubMed ID: 32573835
[TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
Carhart-Harris RL; Goodwin GM
Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of psilocybin and MDMA in the treatment of mental illness.
Gill H; Gill B; Chen-Li D; El-Halabi S; Rodrigues NB; Cha DS; Lipsitz O; Lee Y; Rosenblat JD; Majeed A; Mansur RB; Nasri F; Ho R; McIntyre RS
Expert Rev Neurother; 2020 Dec; 20(12):1263-1273. PubMed ID: 32954860
[TBL] [Abstract][Full Text] [Related]
19. Psilocybin: A brief overview for psychiatric mental health nurse practitioners.
Fradkin D
Perspect Psychiatr Care; 2022 Jul; 58(3):1200-1203. PubMed ID: 34101846
[TBL] [Abstract][Full Text] [Related]
20. The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.
Whelan TP; Daly E; Puts NA; Smith P; Allison C; Baron-Cohen S; Malievskaia E; Murphy DGM; McAlonan GM
BMC Psychiatry; 2024 Apr; 24(1):319. PubMed ID: 38658877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
